UPPTHERA, Inc.
- Biotech or pharma, therapeutic R&D
Specializing in targeted protein degradation (TPD) technology, UPPTHERA, Inc. provides a proprietary E3 ligase platform and differentiated degrader assets. We are seeking research collaborations and out-licensing opportunities with partners in innovative therapeutic development.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}